How much has Vinci Pharmaceuticals raised?

Vinci Pharmaceuticals has raised $8M in one sourced round on record (Series A), announced October 8, 2026.

Who invested in Vinci Pharmaceuticals?

Investors on record for Vinci Pharmaceuticals: Dynagrow Capital, MintPharma Capital and Third Seven Capital. Dynagrow Capital led its latest sourced round.

Who works at Vinci Pharmaceuticals?

Team members on record: Philip Gioia (Chief Executive Officer).

Where is Vinci Pharmaceuticals based?

Vinci Pharmaceuticals is based in Avon By The Sea, United States.

Vinci Pharmaceuticals

Vinci Pharmaceuticals is a health care company that treats retinal diseases.

Health and bio

Latest funding

$8M Series A · October 8, 2026

Led by Dynagrow Capital · Source: finsmes.com

Funding history ↓

Website: vincipharmaceuticals.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Health Care, Medical, Medical Device.

Stage: Series A.

Based in: Avon By The Sea, United States.

Last round: Oct 8, 2026 · 15 days ago.

Domain age: 7 years.

On Recent Funding since: Oct 9, 2026.

About Vinci Pharmaceuticals

Vinci Pharmaceuticals is a company based in Avon By The Sea, United States. Recent Funding lists it under Health and bio. It raised $8M in a Series A round in October 2026, led by Dynagrow Capital, according to finsmes.com. Investors on record include MintPharma Capital and Third Seven Capital. Its team on record includes Philip Gioia (Chief Executive Officer).

Funding rounds

October 8, 2026
Series A · $8M
DDynagrow Capital (lead), MMintPharma Capital
Source: finsmes.com
August 9, 2019
Website created

Team

PG
Philip Gioia Chief Executive Officer

Investors

Similar Health and bio companies

HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026

Other companies backed by Dynagrow Capital

AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026

Dynagrow Capital portfolio →

Questions and sources

Vinci Pharmaceuticals: questions and answers

How much has Vinci Pharmaceuticals raised?: Vinci Pharmaceuticals has raised $8M in one sourced round on record (Series A), announced October 8, 2026.
Who invested in Vinci Pharmaceuticals?: Investors on record for Vinci Pharmaceuticals: Dynagrow Capital, MintPharma Capital and Third Seven Capital. Dynagrow Capital led its latest sourced round.
Who works at Vinci Pharmaceuticals?: Team members on record: Philip Gioia (Chief Executive Officer).
Where is Vinci Pharmaceuticals based?: Vinci Pharmaceuticals is based in Avon By The Sea, United States.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vinci-pharmaceuticals (get a free API key).